1293 related articles for article (PubMed ID: 26699311)
1. Analysis of direct clinical consequences of MLC positional errors in volumetric-modulated arc therapy using 3D dosimetry system.
Nithiyanantham K; Mani GK; Subramani V; Mueller L; Palaniappan KK; Kataria T
J Appl Clin Med Phys; 2015 Sep; 16(5):296–305. PubMed ID: 26699311
[TBL] [Abstract][Full Text] [Related]
2. Quantitative evaluation of 3D dosimetry for stereotactic volumetric-modulated arc delivery using COMPASS.
Vikraman S; Manigandan D; Karrthick KP; Sambasivaselli R; Senniandavar V; Ramu M; Rajesh T; Lutz M; Muthukumaran M; Karthikeyan N; Tejinder K
J Appl Clin Med Phys; 2014 Jan; 16(1):5128. PubMed ID: 25679152
[TBL] [Abstract][Full Text] [Related]
3. Dosimetric impact and detectability of multi-leaf collimator positioning errors on Varian Halcyon.
Gay SS; Netherton TJ; Cardenas CE; Ger RB; Balter PA; Dong L; Mihailidis D; Court LE
J Appl Clin Med Phys; 2019 Aug; 20(8):47-55. PubMed ID: 31294923
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of MLC leaf positioning accuracy for static and dynamic IMRT treatments using DAVID in vivo dosimetric system.
Karagoz G; Zorlu F; Yeginer M; Yildiz D; Ozyigit G
J Appl Clin Med Phys; 2016 Mar; 17(2):14-23. PubMed ID: 27074451
[TBL] [Abstract][Full Text] [Related]
5. Multi-institutional investigation into the robustness of intra-cranial multi-target stereotactic radiosurgery plans to delivery errors.
May L; Hardcastle N; Hernandez V; Saez J; Rosenfeld A; Poder J
Med Phys; 2024 Feb; 51(2):910-921. PubMed ID: 38141043
[TBL] [Abstract][Full Text] [Related]
6. Do technological advances in linear accelerators improve dosimetric outcomes in stereotaxy? A head-on comparison of seven linear accelerators using volumetric modulated arc therapy-based stereotactic planning.
Sarkar B; Pradhan A; Munshi A
Indian J Cancer; 2016; 53(1):166-73. PubMed ID: 27146771
[TBL] [Abstract][Full Text] [Related]
7. Dosimetric effects of multileaf collimator leaf width on intensity-modulated radiotherapy for head and neck cancer.
Hong CS; Ju SG; Kim M; Kim JI; Kim JM; Suh TS; Han Y; Ahn YC; Choi DH; Nam H; Park HC
Med Phys; 2014 Feb; 41(2):021712. PubMed ID: 24506603
[TBL] [Abstract][Full Text] [Related]
8. Clinical implementation of intensity-modulated arc therapy.
Yu CX; Li XA; Ma L; Chen D; Naqvi S; Shepard D; Sarfaraz M; Holmes TW; Suntharalingam M; Mansfield CM
Int J Radiat Oncol Biol Phys; 2002 Jun; 53(2):453-63. PubMed ID: 12023150
[TBL] [Abstract][Full Text] [Related]
9. Monte Carlo dose verification of VMAT treatment plans using Elekta Agility 160-leaf MLC.
Onizuka R; Araki F; Ohno T
Phys Med; 2018 Jul; 51():22-31. PubMed ID: 30278982
[TBL] [Abstract][Full Text] [Related]
10. Impact of the MLC leaf-tip model in a commercial TPS: Dose calculation limitations and IROC-H phantom failures.
Koger B; Price R; Wang D; Toomeh D; Geneser S; Ford E
J Appl Clin Med Phys; 2020 Feb; 21(2):82-88. PubMed ID: 31961036
[TBL] [Abstract][Full Text] [Related]
11. Biological consequences of MLC calibration errors in IMRT delivery and QA.
Moiseenko V; Lapointe V; James K; Yin L; Liu M; Pawlicki T
Med Phys; 2012 Apr; 39(4):1917-24. PubMed ID: 22482613
[TBL] [Abstract][Full Text] [Related]
12. Incorporating geometric ray tracing to generate initial conditions for intensity modulated arc therapy optimization.
Oliver M; Gladwish A; Craig J; Chen J; Wong E
Med Phys; 2008 Jul; 35(7):3137-50. PubMed ID: 18697539
[TBL] [Abstract][Full Text] [Related]
13. Quantification of residual dose estimation error on log file-based patient dose calculation.
Katsuta Y; Kadoya N; Fujita Y; Shimizu E; Matsunaga K; Matsushita H; Majima K; Jingu K
Phys Med; 2016 May; 32(5):701-5. PubMed ID: 27162084
[TBL] [Abstract][Full Text] [Related]
14. Sensitivity of volumetric modulated arc therapy patient specific QA results to multileaf collimator errors and correlation to dose volume histogram based metrics.
Coleman L; Skourou C
Med Phys; 2013 Nov; 40(11):111715. PubMed ID: 24320423
[TBL] [Abstract][Full Text] [Related]
15. A comprehensive formulation for volumetric modulated arc therapy planning.
Nguyen D; Lyu Q; Ruan D; O'Connor D; Low DA; Sheng K
Med Phys; 2016 Jul; 43(7):4263. PubMed ID: 27370141
[TBL] [Abstract][Full Text] [Related]
16. Treatment plan comparison between helical tomotherapy and MLC-based IMRT using radiobiological measures.
Mavroidis P; Ferreira BC; Shi C; Lind BK; Papanikolaou N
Phys Med Biol; 2007 Jul; 52(13):3817-36. PubMed ID: 17664579
[TBL] [Abstract][Full Text] [Related]
17. Texture analysis on the fluence map to evaluate the degree of modulation for volumetric modulated arc therapy.
Park SY; Kim IH; Ye SJ; Carlson J; Park JM
Med Phys; 2014 Nov; 41(11):111718. PubMed ID: 25370632
[TBL] [Abstract][Full Text] [Related]
18. Validation of a new control system for Elekta accelerators facilitating continuously variable dose rate.
Bertelsen A; Lorenzen EL; Brink C
Med Phys; 2011 Aug; 38(8):4802-10. PubMed ID: 21928653
[TBL] [Abstract][Full Text] [Related]
19. Monte Carlo based IMRT dose verification using MLC log files and R/V outputs.
Luo W; Li J; Price RA; Chen L; Yang J; Fan J; Chen Z; McNeeley S; Xu X; Ma CM
Med Phys; 2006 Jul; 33(7):2557-64. PubMed ID: 16898460
[TBL] [Abstract][Full Text] [Related]
20. Volumetric modulated arc therapy: planning and evaluation for prostate cancer cases.
Zhang P; Happersett L; Hunt M; Jackson A; Zelefsky M; Mageras G
Int J Radiat Oncol Biol Phys; 2010 Apr; 76(5):1456-62. PubMed ID: 19540062
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
